School Of Medicine Basic Sciences
-
Vanderbilt researchers identify key molecular driver in aggressive thyroid cancer
Researchers discovered that the protein tenascin-C is a crucial molecular player in the aggressiveness of anaplastic thyroid cancer. The results could lead to better targeted therapeutics for thyroid cancer. Read MoreApr. 3, 2025
-
To cause cancer or not to cause cancer: What leads to H. pylori-induced stomach malignancies
Researchers from the Vanderbilt University Medical Center and Vanderbilt University have figured out how two bacterial elements present in only some Helicobacter pylori strains lead to molecular changes in host tissues that favor the development of gastric cancer. Read MoreApr. 2, 2025
-
UC San Diego Professor of Pharmacology Jin Zhang will deliver Apex Lecture on April 17
University of California, San Diego, Professor of Pharmacology Jin Zhang will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on April 17, 2025. Read MoreApr. 2, 2025
-
From beef to breakthrough: How purifying muscle receptors yielded insights into autoimmune diseases
University of California, San Diego, faculty member Ryan Hibbs delivered a School of Medicine Basic Sciences Apex Lecture on March 27, presenting about muscle acetylcholine receptors in development and disease. Read MoreApr. 1, 2025
-
School of Medicine Basic Sciences Staff Spotlight: Ashley Haddard
Meet Ashley Haddard, the senior program manager for research for the Department of Pharmacology in the Vanderbilt School of Medicine Basic Sciences. Read MoreMar. 28, 2025
-
Vanderbilt basic science alum Q&A: Anne Taylor
Anne Taylor, PhD'23, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her career. Taylor is now a fellow at the Center for Opioid Research, Education & Outreach at the Auburn University Harrison College of Pharmacy. Read MoreMar. 25, 2025
-
School of Medicine Basic Sciences Staff Spotlight: David Baughman
Meet David Baughman, the research program manager for the Vanderbilt Institute of Chemical Biology. Read MoreMar. 13, 2025
-
Vanderbilt researchers identify potential drug combinations to improve breast cancer treatment
Triple-negative breast cancer accounts for 10 percent of breast cancer cases in the U.S. annually. As T-cells that normally kill cancer cells often become exhausted and stop, Vanderbilt pharmacologists are seeking chemotherapy or targeted therapy approaches that can enhance the T-cell killing of cancer cells. Read MoreMar. 10, 2025
-
Study uncovers significant differences in a dietary supplement’s key ingredient
New research by Vanderbilt pharmacologists has uncovered inconsistencies in the active ingredient levels of a dietary supplement often referred to as corydalis. The work, published in Frontiers in Pharmacology, highlights concerns regarding the efficacy and authenticity of these widely used supplements. Read MoreMar. 3, 2025
-
UC San Diego Professor and Chair of Neurobiology Ryan Hibbs to deliver Apex Lecture on March 27
Ryan Hibbs, professor and chair of neurobiology at the University of California, San Diego, will present the Vanderbilt School of Medicine Basic Sciences Apex Lecture on March 27, 2025. Read MoreMar. 3, 2025